Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Alterations in Muscle Tone ll

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Concussion Management for Children Has Changed: New Pediatric Protocols Using the Latest Evidence.

Clinical pediatrics·2019

Same author

Does early antipsychotic response predict long-term treatment outcome?

Human psychopharmacology·2017

Same author

Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology.

World journal of psychiatry·2017

Same author

The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.

Journal of clinical psychopharmacology·2016

Same author

The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.

Psychiatry research·2016

Same author

Cushing Disease Presenting as Primary Psychiatric Illness: A Case Report and Literature Review.

Journal of psychiatric practice·2015

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

Catatonia and its treatment.

Patricia I Rosebush¹, Michael F Mazurek

¹Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario L8P 3B6, Canada. Rosebush@HHSC.CA

Schizophrenia Bulletin

|December 9, 2009

Summary

Catatonia, a syndrome often linked to schizophrenia, affects 10% of psychiatric patients. Effective benzodiazepine treatment for catatonia in affective disorders highlights its distinct, treatable nature.

Area of Science:

Neuroscience
Psychiatry
Clinical Medicine

Background:

Catatonia is often misdiagnosed as a schizophrenia subtype, despite its prevalence in other psychiatric conditions.
Approximately 10% of acutely ill psychiatric patients exhibit catatonia, with a significant portion having comorbid affective disorders.

Discussion:

Catatonia in affective disorders often responds dramatically to benzodiazepine therapy, unlike in schizophrenia, suggesting different underlying mechanisms.
Concurrent psychosis is common in catatonia, and delaying catatonia treatment before antipsychotic initiation risks neuroleptic malignant syndrome.

Key Insights:

Catatonia is a distinct, treatable neuropsychiatric syndrome, not solely a schizophrenia subtype.
Benzodiazepine responsiveness varies significantly between catatonia subtypes, indicating differential pathophysiology.

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Related Experiment Videos

Last Updated: Jun 18, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Early recognition and treatment of catatonia are crucial to prevent complications like neuroleptic malignant syndrome.

Outlook:

Further research into catatonia's pathobiology is needed to establish it as a separate diagnostic entity.
Improved diagnostic criteria for catatonia could enhance patient recognition and treatment outcomes.
Investigating the neurobiological underpinnings of catatonia may reveal novel therapeutic targets.